The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EU mergers and takeovers (Oct 23)

Wed, 23rd Oct 2013 11:17

BRUSSELS, Oct 23 (Reuters) - The following are mergers underreview by the European Commission and a brief guide to the EUmerger process:

APPROVALS AND WITHDRAWALS

-- U.S. group Koch Industries to acquireelectronic components maker Molex (approved Oct. 23)

NEW LISTINGS

-- Japan's Suntory Beverage & Food Ltd to buyBritish drugmaker GlaxoSmithKline Plc's Lucozade andRibena brands (notified Oct. 22/deadline Nov. 27)

-- U.S. bank Goldman Sachs to acquire sole control ofBritish motor insurer Hastings Insurance Group (notified Oct.21/deadline Nov. 26/simplified)

EXTENSIONS AND OTHER CHANGES

None

FIRST-STAGE REVIEWS BY DEADLINE

OCT 24

-- Private equity firm Triton to buy telecoms and energyinfrastructure builder Alpine Energie from Spanish constructiongroup FCC (notified Sept. 19/deadline Oct.24/simplified)

OCT 25

-- Private equity firm CVC Capital Partners to buy some ofCampbell Soup Co's brands (notified Sept. 20/deadlineOct. 25)

OCT 29

-- Dutch dredger Boskalis and investment companyReggeborgh to acquire joint control of subsea power cablessupplier Visser & Smit Marine Contracting B.V. which is nowsolely controlled by Reggeborgh (notified Sept. 24/deadliineOct. 29)

NOV 4

-- Private investment firm TPG and CaixaBank S.A. to set upa property joint venture by acquiring the business of CaixaBankunit Servihabitat (notified Sept. 27/deadline Nov. 4/simplified)

-- Piper Verlag GmbH to acquire a 50 percent stake in thejoint venture G+J RBA GmbH & Co which is now solely owned byGerman publisher Gruner + Jahr AG & Co (notified Sept.27/deadline Nov. 4/simplified)

NOV 5

-- Switzerland-based INEOS and Belgian chemicals companySolvay to form a joint venture (notified Sept.16/deadline extended to Nov. 5 from Oct. 21 after Solvay offeredconcessions)

-- British telecoms operator Vodafone to buy aminority stake in Vodafone Omnitel N.V. from U.S. peer VerizonCommunications Inc (notified Sept. 30/deadline Nov.5/simplified)

NOV 6

-- South African furniture retailer Steinhoff InternationalHoldings to acquire electrical appliances retailerRudolf Leiner Gesellschaft m.b.H. and LKMBeteiligungsgesellschaft m.b.H. (notified Oct. 1/deadline Nov.6/simplified)

-- Hutchison 3G UK to acquire Telefonica Ireland,a unit of Spanish telecoms provider Telefonica (notified Oct. 1/deadline Nov. 6)

NOV 12

-- U.S. maker of scientific and laboratory equipment ThermoFisher Scientific to buy genetic testing equipment makerLife Technologies (notified Oct. 7/deadline Nov. 12)

NOV 14

-- Japanese trading house Mitsui & Co, IskandarInvestment Berhad (IIB) which is majority owned by Malaysianstate investor Khazanah Nasional Berhad, andinvestment company UWI Capital One to acquire joint control ofMedini Iskandar Malaysia Sdn Bhd, which is now jointlycontrolled by IIB and UWI (notified Oct. 9/deadline Nov.14/simplified)

NOV 18

-- U.S. asset management fund Ares Management LLC andCanada's Ontario Teachers Pension Plan Board to acquire jointcontrol of U.S. building products company CPG International LLC,which is now solely controlled by Ares (notified Oct.11/deadline Nov. 18/simplified)

-- Norwegian telecoms operator Telenor to take astake in a venture owned by Norwegian publishing house Schibsted and Singapore Press Holdings, and also to set up ajoint venture with Schibsted focusing on South American business(notified Oct. 11/deadline Nov. 18/simplified)

-- Parkwind, which is an investment vehicle of Belgiansupermarket chain Colruyt Group, and special purposevehicle Summit Renewable Energy, which is owned by Japan'sSumitomo Corp, to acquire joint control of wind farmoperator Belwind 1, which is now solely owned by SummitRenewable Energy (notified Oct. 11/deadline Nov. 18/simplified)

-- French luxury goods company LVMH to buy an 80percent stake in Italian luxury cashmere clothing brand LoroPiana (notified Oct. 11/deadline Nov. 18/simplified)

NOV 21

-- Czech energy company EPH to acquire Slovakian powerdistributor Stredoslovenska Energetika (SSE) from Frenchstate-controlled utility EDF (notified Oct. 15/deadlineNov. 21)

NOV 25

-- Private equity investor 3i Group to acquire sole controlof ferry operator Scandferries Holdings which is now jointlycontrolled by 3i and ACP Affiliates (notified Oct. 18/deadlineNov. 25/simplified)

MARCH 10

-- Swiss cement maker Holcim to buy some ofMexican peer Cemex's assets in Germany (notified Sept. 3/dateline extended to March 10 from Oct. 22after the Commission opened an in-depth investigation into thedeal)

GUIDE TO EU MERGER PROCESS

DEADLINES:

The European Commission has 25 working days after a deal is filed for a first-stage review. It may extend that by 10 workingdays to 35 working days, to consider either a company's proposedremedies or an EU member state's request to handle the case.

Most mergers win approval but occasionally the Commission opens a detailed second-stage investigation for up to 90 additional working days, which it may extend to 105 working days.

SIMPLIFIED:

Under the simplified procedure, the Commission announces theclearance of uncontroversial first-stage mergers without givingany reason for its decision. Cases may be reclassified asnon-simplified -- that is, ordinary first-stage reviews -- untilthey are approved.

More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.